COVID-19 Guideline Part 4: Serologic Testing

Authoring Organization

Publication Month/Year

August 18, 2020

Supplemental Implementation Tools

Document Type


Country of Publication


Document Objectives

IDSA’s goal was to develop evidence-based recommendations that assist clinicians, clinical laboratories, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 serologic tests in a variety of settings. We also highlight important unmet research needs pertaining to the use of anti-SARS-CoV-2 antibody tests for diagnosis, public health surveillance, vaccine development and the selection of convalescent plasma donors.

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Older adult

Health Care Settings

Ambulatory, Hospital, Laboratory services

Intended Users

Epidemiology infection prevention, laboratory technician, nurse, nurse practitioner, physician, physician assistant


Diagnosis, Assessment and screening

Diseases/Conditions (MeSH)

D000086382 - COVID-19, D000087124 - COVID-19 Serological Testing


covid-19, serologic testing, COVID, serological testing